PharmAbcine, a clinical stage immune-oncology company, delivered a presentation at  at the Spring 2021 Oncology Investor Conference, March 29th - April 2, 2021.

This presentation video features Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine, who introduced the core technology and pipeline assets such as Olinvacimab, PMC-309, and PMC-403.

Visit the link for the presentation video

https://www.youtube.com/watch?v=ltAYHQBbezY&t=552s